Search Results

The company announced this today in its presentation of Q3 2024 results, which were affected downward by low salmon and trout prices.

The nomination committee will propose Ørjan Svanevik as his replacement.

Third quarter trading update by the Norwegian seafood giant shows a slight decline in salmon and trout aquaculture harvest volumes, but a notable drop in wild catch of cod.

Presenting the group's Q2 2024 results, CEO Henning Beltestad highlighted "substantial improvements" in fish health, saying submerged cages "will be an important growth driver for Lerøy going forward ...

The investment will support Salmonics' growth and the development of cutting-edge biotechnology solutions using fish blood.

The company's 100% Fish department has succeeded in finding a use for salmon blood by converting it into iron and launching the SalmoFer® brand on the market.